Sparian Biosciences Starts Phase 1 Trial Of SBS-147 Pain Drug
09 Apr 2026 //
GLOBENEWSWIRE
Sparian Biosciences Wins $19.5M NIH/NIDA Grant for SBS-226
14 Nov 2024 //
GLOBENEWSWIRE
Sparian Biosciences Forms Science Advisory Board
13 Nov 2024 //
GLOBENEWSWIRE
Sparian Bio Reports Phase 1 Trial Results of SBS-1000 Analgesic
12 Nov 2024 //
GLOBENEWSWIRE
Sparian Awarded $19M Five-Year NIH/ NIDA Grant to Fund Development of SBS-518
08 Aug 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support